Advertisement

Recurrent, Non-Pitting Edema of Lips, Extremities, and Genitalia

  • Taher CheraghiEmail author
Chapter

Abstract

Idiopathic histaminergic angioedema is responsive to antihistamines

Acquired angioedema often occurs above the age of 40

C1-inhibitor concentrates are either nano-filtered derivatives of plasma, available as Berinert and Cinryz, or recombinant products such as Ruconest

Keywords

Angioedema Hereditory Angioedema Allergic Angioedema C1 inhibitor Non-Pitting Angioedema Histaminergic Angioedema Kininergic Angioedema 

References

  1. 1.
    Cicardi M, Suffritti C, Perego F, Caccia S. Novelties in the diagnosis and treatment of angioedema. J Investig Allergol Clin Immunol. 2016;26(4):212–21; quiz two pages after page 21.CrossRefGoogle Scholar
  2. 2.
    Busse PJ, Smith T. Histaminergic angioedema. Immunol Allergy Clin N Am. 2017;37(3):467–81.CrossRefGoogle Scholar
  3. 3.
    Cicardi M, Aberer W, Banerji A, Bas M, Bernstein JA, Bork K, Caballero T, Farkas H, Grumach A, Kaplan AP, Riedl MA, Triggiani M, Zanichelli A, Zuraw B. EAACI Hutpo. Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group. Allergy. 2014;69(5):602–16.CrossRefGoogle Scholar
  4. 4.
    Zuraw BL, Christiansen SC. How we manage persons with hereditary angioedema. Br J Haematol. 2016;173(6):831–43.CrossRefGoogle Scholar
  5. 5.
    Zuraw B, Christiansen S. Hereditary angioedema and Bradykinin mediated angioedema. In: Middleton’s allergy: principles and practice, vol. 1; 2014. p. 588–601.Google Scholar
  6. 6.
    Farkas H, Martinez-Saguer I, Bork K, Bowen T, Craig T, Frank M, Germenis AE, Grumach AS, Luczay A, Varga L, Zanichelli A. International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency. Allergy. 2017;72(2):300–13.CrossRefGoogle Scholar
  7. 7.
    Kaplan AP. Enzymatic pathways in the pathogenesis of hereditary angioedema: the role of C1 inhibitor therapy. J Allergy Clin Immunol. 2010;126(5):918–25.CrossRefGoogle Scholar
  8. 8.
    Zuraw BL. Christiansen SC, Hereditory Angioedema and Bradykinin-Mediated Angioedema In: Adkinson Jr NF, Bochner BS, Burks W, et al editors Middleton Allergy: Principles and Practice 8th edn, Philadelphia: 2014, pp. 588–601Google Scholar
  9. 9.
    Farkas H, Martinez-Saguer I, Bork K, Bowen T, Craig T, Frank M, Germenis AE, Grumach AS, Luczay A, Varga L, Zanichelli A, Hawk. International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency. Allergy. 2017;72(2):300–13.CrossRefGoogle Scholar
  10. 10.
    Moellman JJ, Bernstein JA, Lindsell C, Banerji A, Busse PJ, Camargo CA, Collins SP, Craig TJ, Lumry WR, Nowak R. A consensus parameter for the evaluation and management of angioedema in the emergency department. Acad Emerg Med. 2014;21(4):469–84.CrossRefGoogle Scholar
  11. 11.
    Walford HH, Zuraw BL. Current update on cellular and molecular mechanisms of hereditary angioedema. Ann Allergy Asthma Immunol. 2014;112(5):413–8.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Department of Pediatrics17th Shahrivar Children’s Hospital, School of Medicine, Guilan University of Medical SciencesRashtIran

Personalised recommendations